Free Trial

Daxor (DXR) Competitors

Daxor logo
$9.83 +0.08 (+0.82%)
As of 07/3/2025 12:54 PM Eastern

DXR vs. ELMD, PROF, INGN, KRMD, CVRX, LNSR, AVR, PDEX, RCEL, and LAKE

Should you be buying Daxor stock or one of its competitors? The main competitors of Daxor include Electromed (ELMD), Profound Medical (PROF), Inogen (INGN), KORU Medical Systems (KRMD), CVRx (CVRX), LENSAR (LNSR), Anteris Technologies Global (AVR), Pro-Dex (PDEX), Avita Medical (RCEL), and Lakeland Industries (LAKE). These companies are all part of the "medical equipment" industry.

Daxor vs. Its Competitors

Electromed (NYSE:ELMD) and Daxor (NASDAQ:DXR) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, media sentiment, earnings, dividends, risk, institutional ownership, profitability and valuation.

Electromed presently has a consensus price target of $38.00, indicating a potential upside of 82.87%. Daxor has a consensus price target of $25.00, indicating a potential upside of 154.32%. Given Daxor's higher probable upside, analysts plainly believe Daxor is more favorable than Electromed.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Electromed
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
4.00
Daxor
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

40.8% of Electromed shares are owned by institutional investors. Comparatively, 1.3% of Daxor shares are owned by institutional investors. 14.0% of Electromed shares are owned by insiders. Comparatively, 59.5% of Daxor shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Electromed has a beta of 0.41, indicating that its stock price is 59% less volatile than the S&P 500. Comparatively, Daxor has a beta of -0.07, indicating that its stock price is 107% less volatile than the S&P 500.

Electromed has a net margin of 11.34% compared to Daxor's net margin of 0.00%. Electromed's return on equity of 15.71% beat Daxor's return on equity.

Company Net Margins Return on Equity Return on Assets
Electromed11.34% 15.71% 13.37%
Daxor N/A N/A N/A

In the previous week, Electromed had 1 more articles in the media than Daxor. MarketBeat recorded 1 mentions for Electromed and 0 mentions for Daxor. Electromed's average media sentiment score of 0.00 equaled Daxor'saverage media sentiment score.

Company Overall Sentiment
Electromed Neutral
Daxor Neutral

Electromed has higher revenue and earnings than Daxor.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Electromed$61.44M2.84$5.15M$0.7926.30
DaxorN/AN/AN/AN/AN/A

Summary

Electromed beats Daxor on 9 of the 12 factors compared between the two stocks.

Get Daxor News Delivered to You Automatically

Sign up to receive the latest news and ratings for DXR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DXR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DXR vs. The Competition

MetricDaxorMED IndustryMedical SectorNASDAQ Exchange
Market Cap$47.55M$3.91B$5.53B$9.04B
Dividend YieldN/A1.27%5.24%4.01%
P/E RatioN/A35.6227.6420.25
Price / SalesN/A18.00416.59118.23
Price / CashN/A24.0336.8958.07
Price / BookN/A4.398.035.67
Net IncomeN/A$189.47M$3.18B$249.21M
7 Day Performance7.43%-1.09%2.92%3.28%
1 Month Performance10.70%-4.38%3.72%5.55%
1 Year Performance11.70%8.86%35.14%21.08%

Daxor Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DXR
Daxor
N/A$9.83
+0.8%
$25.00
+154.3%
+15.1%$47.55MN/A0.0037Gap Down
ELMD
Electromed
1.2333 of 5 stars
$21.65
+1.9%
$38.00
+75.5%
+42.1%$181.56M$61.44M28.87160News Coverage
PROF
Profound Medical
2.6773 of 5 stars
$6.20
+3.2%
$11.50
+85.5%
-30.9%$180.62M$10.68M-5.08150
INGN
Inogen
4.4154 of 5 stars
$7.05
+5.7%
$11.00
+56.0%
-10.4%$179.34M$335.70M-6.131,030
KRMD
KORU Medical Systems
2.0747 of 5 stars
$3.56
+3.8%
$4.50
+26.4%
+42.5%$158.26M$33.65M-32.3680High Trading Volume
CVRX
CVRx
2.7486 of 5 stars
$6.07
+6.1%
$14.50
+138.9%
-44.0%$149.13M$51.29M-2.78160Positive News
LNSR
LENSAR
1.4068 of 5 stars
$12.49
+2.0%
$15.00
+20.1%
+189.2%$144.34M$53.49M-2.58110News Coverage
AVR
Anteris Technologies Global
N/A$4.03
+6.1%
$16.50
+309.4%
N/A$137.04M$2.70M0.00138News Coverage
Positive News
PDEX
Pro-Dex
2.4928 of 5 stars
$42.37
+1.3%
$56.00
+32.2%
+178.5%$136.38M$53.84M15.13140Positive News
High Trading Volume
RCEL
Avita Medical
0.8784 of 5 stars
$4.94
-3.9%
$16.50
+234.0%
-29.2%$135.87M$64.25M-2.26130High Trading Volume
LAKE
Lakeland Industries
4.8318 of 5 stars
$14.04
+0.1%
$26.00
+85.2%
-39.2%$133.49M$167.21M-4.662,100High Trading Volume

Related Companies and Tools


This page (NASDAQ:DXR) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners